secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001493152-24-041633
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics posts updated corporate presentation on its website
--------------------------------------------------------------------------

- Calidi Biotherapeutics made an updated corporate presentation available on its website on October 18, 2024.
- The presentation is intended for investor relations purposes and contains no new financial or clinical disclosures.
- No material events such as M&A, leadership changes, or clinical milestones were reported in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224041633/0001493152-24-041633-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224041633/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041633

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer